Journal of Clinical Epidemiology
Volume 55, Issue 1 , Pages 25-31 , January 2002

Risk tables for parkinsonism and Parkinson's disease

  • Alexis Elbaz

      Affiliations

    • Department of Health Sciences Research, Mayo Clinic and Mayo Foundation, 200 First Street SW, Rochester, MN 55905, USA
    • ,
  • James H Bower

      Affiliations

    • Department of Neurology, Mayo Clinic and Mayo Foundation, 200 First Street SW, Rochester, MN 55905, USA
    • ,
  • Demetrius M Maraganore

      Affiliations

    • Department of Neurology, Mayo Clinic and Mayo Foundation, 200 First Street SW, Rochester, MN 55905, USA
    • ,
  • Shannon K McDonnell

      Affiliations

    • Department of Health Sciences Research, Mayo Clinic and Mayo Foundation, 200 First Street SW, Rochester, MN 55905, USA
    • ,
  • Brett J Peterson

      Affiliations

    • Department of Health Sciences Research, Mayo Clinic and Mayo Foundation, 200 First Street SW, Rochester, MN 55905, USA
    • ,
  • J.Eric Ahlskog

      Affiliations

    • Department of Neurology, Mayo Clinic and Mayo Foundation, 200 First Street SW, Rochester, MN 55905, USA
    • ,
  • Daniel J Schaid

      Affiliations

    • Department of Health Sciences Research, Mayo Clinic and Mayo Foundation, 200 First Street SW, Rochester, MN 55905, USA
    • ,
  • Walter A Rocca

      Affiliations

    • Department of Health Sciences Research, Mayo Clinic and Mayo Foundation, 200 First Street SW, Rochester, MN 55905, USA
    • Department of Neurology, Mayo Clinic and Mayo Foundation, 200 First Street SW, Rochester, MN 55905, USA
    • Corresponding Author InformationCorresponding author. Tel.: 507-284-3568; fax: 507-284-1516. E-mail address:(W.A. Rocca)

Received 2 April 2001 ,Revised 29 June 2001 ,Accepted 12 July 2001.

References 

  1. Checkoway H, Nelson LM. Epidemiologic approaches to the study of Parkinson's disease etiology. Epidemiology. 1999;10:327–336
  2. de Rijk MC, Tzourio C, Breteler MMB, Dartigues JF, Amaducci L, Lopez-Pousa S, et al. Prevalence of parkinsonism and Parkinson's disease in Europe (the EUROPARKINSON collaborative study). J Neurol Neurosurg Psychiatry. 1997;62:10–15
  3. Bower JH, Maraganore DM, McDonnell SK, Rocca WA. Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976–1990. Neurology. 1999;52:1214–1220
  4. Mayeux R, Marder K, Cote LJ, Denaro J, Hemenegildo N, Mejia H, et al. The frequency of idiopathic Parkinson's disease by age, ethnic group, and sex in northern Manhattan, 1988–1993. Am J Epidemiol. 1995;142:820–827
  5. Baldereschi M, Di Carlo A, Rocca WA, Vanni P, Maggi S, Perissinotto E, et al. Parkinson's disease and parkinsonism in a longitudinal study. Two-fold higher incidence in men. Neurology. 2000;55:1358–1363
  6. Morens DM, Davis JW, Grandinetti A, Ross GW, Popper JS, White LR. Epidemiologic observations on Parkinson's disease (incidence and mortality in a prospective study of middle-aged men). Neurology. 1996;46:1044–1050
  7. Goldberg ID, Levin ML, Gerhardt PR, Handy VH, Cashman RE. The probability of developing cancer. J Natl Cancer Inst. 1956;17:155–173
  8. Zdeb MS. The probability of developing cancer. Am J Epidemiol. 1977;106:6–16
  9. Bender AP, Punyko J, Williams AN, Bushhouse SA, Section of Chronic Disease and Environmental Epidemiology, Minnesota Department of Health . A standard person-years approach to estimating lifetime cancer risk. Cancer Causes Control. 1992;3:69–75
  10. Breitner JCS. Clinical genetics and genetic counseling in Alzheimer disease. Ann Intern Med. 1991;115:601–606
  11. Seshadri S, Wolf PA, Beiser A, Au R, McNulty K, White R, et al. Lifetime risk of dementia and Alzheimer's disease. The impact of mortality on risk estimates in the Framingham Study. Neurology. 1997;49:1498–1504
  12. Ott A, Breteler MMB, van Harskamp F, Stijnen T, Hofman A. Incidence and risk of dementia. The Rotterdam Study. Am J Epidemiol. 1998;147:574–580
  13. National Center for Disease Health Statistics . U.S. decennial life tables for 1989–91, vol II, State life tables no. 24, Minnesota. Hyattsville, MD: National Center for Health Statistics; 1998;
  14. Kurland LT, Molgaard CA. The patient record in epidemiology. Sci Am. 1981;245:54–63
  15. Melton LJ. History of the Rochester Epidemiology Project. Mayo Clin Proc. 1996;71:266–274
  16. Commission on Professional and Hospital Activities . Hospital Adaptation of ICDA– H-ICDA. 2nd ed. Ann Arbor, MI: Commission on Professional and Hospital Activities; 1973;
  17. Anderson RN. U.S. decennial life tables for 1989–91, vol 1 no 4, United States life tables eliminating certain causes of death. Hyattsville, MD: National Center for Health Statistics; 1999;
  18. Minnesota Department of Health. Lifetime risk of developing cancer. Minneapolis, Minnesota: Minnesota Department of Health 1990; MCSS Technical Report No. 90:1.
  19. Rothman KJ, Greenland S. Modern epidemiology. 2nd ed. Philadelphia, PA: Lippincott-Raven Publishers; 1998;
  20. Schouten LJ, Straatman H, Kiemeney LALM, Verbeek ALM. Cancer incidence (life table risk versus cumulative risk). J Epidemiol Community Health. 1994;48:596–600
  21. Marder K, Tang M-X, Mejia H, Alfaro B, Côté L, Louis E, et al. Risk of Parkinson's disease among first-degree relatives (a community-based study). Neurology. 1996;47:155–160
  22. Feuer EJ, Wun L-M, Boring CC, Flanders WD, Timmel MJ, Tong T. The lifetime risk of developing breast cancer. J Natl Cancer Inst. 1993;85:892–897
  23. Black DM, Cummings SR, Melton LJ. Appendicular bone mineral and a woman's lifetime risk of hip fracture. J Bone Miner Res. 1992;7:639–646
  24. Rocca WA, Bower JH, McDonnell SK, Peterson BJ, Maraganore DM. Time trends in the incidence of parkinsonism in Olmsted County, Minnesota. Neurology. 2001;57:462–467
  25. Paulson GW, Gill WM. Are death certificates reliable to estimate the incidence of Parkinson's disease?. Mov Disord. 1995;10:678;[ Letter]

PII: S0895-4356(01)00425-5

Journal of Clinical Epidemiology
Volume 55, Issue 1 , Pages 25-31 , January 2002

Article Tools

* Image Usage & Resolution